Search clinical trials for: Prostatic
Total 6563 results
-
Herlev HospitalEli Lilly and Company; SanofiCompleted
-
Wirral University Teaching Hospital NHS TrustCompleted
-
Tel-Aviv Sourasky Medical CenterHerzog HospitalUnknownBreast Cancer | Prostate Cancer | Dyadic CopingIsrael
-
Cytogen CorporationUnknownMetastatic Prostate CancerUnited States
-
Ziv HospitalUnknown
-
Wirral University Teaching Hospital NHS TrustNovartisCompleted
-
AbbottCompletedProstatic NeoplasmsCanada, United States, Spain, Belgium, Australia, Italy, United Kingdom, Germany, France, Sweden, South Africa, Netherlands, Ireland, New Zealand, Greece, Poland, Austria
-
Stanford UniversityUnited States Department of DefenseCompletedProstate CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
McGill University Health Centre/Research Institute...UnknownPain | Breast Cancer | Prostate Cancer | Vertebral MetastasisCanada
-
VA Puget Sound Health Care SystemSchiffler Cancer CenterCompletedProstate CancerUnited States
-
VA Puget Sound Health Care SystemSchiffler Cancer CenterUnknown
-
VA Puget Sound Health Care SystemDr. Gregory Merrick; Theragenics CorporationUnknown
-
Eli Lilly and CompanyCompleted
-
Pharmacyclics LLC.CompletedBreast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian NeoplasmsUnited States
-
Tampere UniversityCompleted
-
ProstaPlant Urology System Ltd.UnknownBenign Prostatic HyperplasiaIsrael
-
Hospices Civils de LyonUnknown
-
Urology of VirginiaGlaxoSmithKlineUnknownLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
ProteoSys AGCharite University, Berlin, Germany; Medical University Innsbruck; University... and other collaboratorsUnknownBenign Prostatic Hyperplasia | Prostate Cancer | Prostatic Intraepithelial Neoplasia
-
BZL BiologicsCompletedPhase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2Prostatic NeoplasmsUnited States
-
Assaf-Harofeh Medical CenterUnknown
-
Celgene CorporationCompletedSafety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)Prostate CancerUnited States
-
Morton Plant Mease Health CareOrtho Biotech Products, L.P.TerminatedProstate CancerUnited States
-
TransgeneUniversity of California, Los Angeles; The Cleveland Clinic; University of ArizonaTerminated
-
Universiti Sains MalaysiaUniversity of WashingtonCompleted
-
QLT Inc.TerminatedProstatic HyperplasiaUnited States, Canada
-
PRAECIS Pharmaceuticals Inc.CompletedProstate CancerUnited States
-
Kaunas University of MedicineUnknown
-
Gustave Roussy, Cancer Campus, Grand ParisSuspended
-
Gustave Roussy, Cancer Campus, Grand ParisTerminatedProstate CancerFrance
-
National Center for Complementary and Integrative...CompletedBreast Neoplasms | Prostatic Neoplasms | Colorectal Neoplasms | Ovarian NeoplasmsUnited States
-
AbbottCompletedProstatic NeoplasmsUnited States, Canada
-
AbbottCompletedProstate CancerUnited States, Canada, France, Spain, Belgium, Australia, United Kingdom, Italy, Sweden, South Africa, Netherlands, Ireland, Germany, Austria, New Zealand, Greece, Poland, Switzerland
-
NovaceaUnknownNon Small Cell Lung Cancer (NSCLC) | Androgen Independent Prostate Cancer (AIPC)Canada, United States
-
Tampere UniversityFinnish Prostate Cancer GroupUnknownPatients With T1-4 Advanced Prostate CancerFinland
-
Cell GenesysTerminatedProstate CancerUnited States
-
Ontario Cancer Research NetworkUnknown
-
Dattoli Cancer Center and Brachytherapy Research...SanofiCompletedProstate Cancer Patients Undergoing External Radiation and Seed ImplantationUnited States
-
National Taiwan University HospitalUnknown
-
Celgene CorporationPrologue Research InternationalTerminated
-
Department of Veterans Affairs, New JerseyPfizerUnknownA Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerProstate CancerUnited States
-
Department of Veterans Affairs, New JerseySanofi; PfizerUnknownProstate CancerUnited States
-
Emory UniversityCompletedProstate CancerUnited States
-
Centers for Disease Control and PreventionUnknownProstate CancerUnited States